Absci · conference-presentation
Absci | Investor Presentation Deck | 111 slides
111 pages · 5 arc beats · 2 loops
Absci | Investor Presentation Deck | 111 slides
Absci · 2023-10 arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
15101520253035404550556065707580859095100105110111
Deck intelligence map
5 coverage by narrative range · generated from this deck JSON
Narrative range 13 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Attention 4 slides 100% 4/4 slides 100% 4/4 slides · 16 hits — 0/4 slides
50% 2/4 slides — 0/4 slides
100% 4/4 slides — 0/4 slides
Problem (Identify pain) 2 slides 100% 2/2 slides 100% 2/2 slides · 15 hits — 0/2 slides
100% 2/2 slides · 3 hits 100% 2/2 slides 100% 2/2 slides 100% 2/2 slides Solution (Provide relief) 2 slides 100% 2/2 slides 100% 2/2 slides · 11 hits — 0/2 slides
100% 2/2 slides 100% 2/2 slides 100% 2/2 slides — 0/2 slides
Call to Adventure 2 slides 100% 2/2 slides 100% 2/2 slides · 8 hits — 0/2 slides
— 0/2 slides
100% 2/2 slides 100% 2/2 slides 100% 2/2 slides Satisfaction 3 slides 100% 3/3 slides 100% 3/3 slides · 11 hits — 0/3 slides
66.7% 2/3 slides — 0/3 slides
100% 3/3 slides — 0/3 slides
Slide inventory
111 every slide · same image gating as the playbook
01
The slide uses Python-like code snippets as a design element to illustrate the technical nature of the drug creation process.front_matter
Open slide detailBeat · Attention
04
Includes decorative code snippets in the background and a stylized geometric logo.front_matter
Open slide detailBeat · Attention
06
Uses a timeline chart to show the acceleration of AI technology (Image recognition -> NLP -> DALL-E -> ChatGPT) to set the stage for the company's value proposiframe_situation
07
The diagram shows a circular, inefficient optimization process (affinity, developability, toxicity) leading to suboptimal candidates.diagnose_problem
08
The slide uses a comparison frame to contrast small molecule data availability with biologic data scarcity.frame_problem
09
The slide uses a process flow to explain the technical solution.present_solution
Open slide detailBeat · Solution (Provide relief)
10
The slide uses a circular flywheel diagram to represent the iterative process.present_framework
Open slide detailBeat · Solution (Provide relief)
11
The slide uses QR codes to link to specific research papers (Shanehsazzadeh et al. 2023, Constant et al. 2023, Bachas et al. 2022).summarize
12
The slide uses a linear process flow with icons representing AI intervention at each stage.present_solution
13
The slide uses a structured column-based layout to map specific technical capabilities to strategic business outcomes.present_solution
14
Includes a 'Chief Morale Officer' (a dog) as a lighthearted team member.introduce_nominees
15
The slide uses a horizontal timeline with icons representing different types of events (IPO, partnerships, research, leadership).summarize
20
Includes a headshot, bulleted career history, and a logo grid of associated organizations.introduce_nominees
21
The slide uses a three-column layout to summarize the company's core strengths.summarize
22
The slide uses a split-column layout to contrast leadership in two distinct functional areas.introduce_nominees
24
The slide uses a circular flywheel diagram to represent the integration of data, wet-lab validation, and AI creation.summarize
25
The slide illustrates the Absci platform's workflow, highlighting the integration of AI in both discovery and optimization stages.present_solution
29
The slide uses a structured grid to map technical capabilities to business outcomes.present_solution
30
The slide uses a structured column layout to map specific technical capabilities to strategic business outcomes.present_solution
31
Uses a timeline framework to contrast traditional drug development timelines with Absci's accelerated approach.present_solution
32
Uses a before-after framing to contrast industry benchmarks with Absci's performance metrics.compare_peers
33
The chart uses a horizontal bar structure to represent stages of development.plan_implementation
34
The chart uses a grouped bar format to compare five economic categories: Research Funding/Cost, Upfront Payment, Clinical Milestones, Commercial Milestones, andcompare_peers
35
The slide uses a grouped bar chart to demonstrate the value-add of internal development stages.analyze_data
36
The donut charts illustrate the concept of a diversified portfolio, while the text box details the specific characteristics of the two partnership models.present_framework
41
The slide uses a bracket to highlight which members of the leadership team are speaking today.introduce_nominees
42
The slide uses a timeline-like visual to anchor two specific hiring events against a set of five strategic pillars.summarize
43
The slide uses a process flow diagram to illustrate the AI-driven drug development pipeline.present_solution
45
The slide includes Python-like code snippets in the background, likely illustrating the company's computational biology workflow.transition
48
The slide uses a timeline-like list to show career progression, followed by a visual showcase of current projects.other
49
The slide uses nested rectangular blocks to represent overlapping eras of AI development.establish_context
50
The slide uses a simple block diagram to represent the core mechanism of an LLM.present_framework
51
The slide uses a simple input-process-output flow to explain the core function of an LLM.present_framework
53
The slide uses a simple input-process-output flow to demystify LLM architecture.present_framework
54
The slide uses a simple input-process-output flow to demystify LLM functionality.present_framework
55
The slide uses a simple input-process-output flow to explain LLM token prediction.present_framework
56
The slide uses a simple input-process-output flow to explain LLM inference.present_framework
57
Uses a simple input-process-output flow to demystify LLM inference.present_framework
58
The slide uses a simple input-process-output flow to demystify LLM inference.present_framework
59
Uses a central block to represent the Transformer architecture as a black-box processor.present_framework
60
The slide uses a simple input-process-output flow to demystify LLM inference.present_framework
62
The slide uses two case studies (DNABERT and ESM) to demonstrate the utility of deep neural networks in biological research.summarize
63
The slide uses a line chart to show the trend of research papers and a 2x3 grid of images to illustrate the practical applications of the technology.summarize
64
The chart illustrates the plateauing of CPU performance (1.1X per year) versus the exponential growth of accelerated computing and AI.analyze_data
65
The chart uses a logarithmic scale to demonstrate the divergence between sequential CPU performance and accelerated computing/AI performance.present_solution
66
The chart uses a logarithmic scale on the Y-axis to show exponential growth differences.present_solution
67
The chart illustrates the divergence between traditional CPU scaling and the accelerated growth enabled by AI and specialized hardware.quantify_opportunity
68
The slide uses a process flow diagram to explain the technical workflow of the company's core technology.present_solution
69
The slide serves as a visual proof-point of the partnership, showing both the physical lab environment and the official announcement.illustrate_case
70
Includes a diagram illustrating the progression from specific task models to general foundation models.present_framework
71
The slide uses a process flow diagram to map specific AI models to stages of drug discovery.present_solution
78
The slide uses a process flow framework to show the integration of AI across the drug development lifecycle.present_solution
79
The slide outlines a proprietary workflow combining AI-driven design with experimental validation.present_solution
80
The slide uses a split-screen layout to contrast project objectives with results.illustrate_case
81
The slide uses a dot plot to show binding affinity vs sequence diversity and a bar chart to compare binding rates.analyze_data
82
The slide shows two dose-response curves (Cell Surface Binding and ADCC) and two molecular surface models for epitope mapping.analyze_data
83
The slide uses a Gantt-style chart to illustrate the overlap of two batches of targets.plan_implementation
84
The slide uses a process flow framework to show the progression from target discovery to optimized antibodies.present_solution
85
The slide features a circular flywheel diagram on the left and a breakdown of the wet lab validation process on the right.present_framework
86
The slide uses molecular visualization of RBD mutations and a table showing KD (binding affinity) values, highlighting the poor binding (607 nM) to the beta varillustrate_case
87
The slide uses a two-step process flow (1 and 2) to explain the technical methodology of their AI-driven drug discovery platform.present_solution
88
The slide uses a process flow (1 -> 2) followed by a scatter plot validation and a summary table of Pearson R values.analyze_data
89
SPR stands for Surface Plasmon Resonance. The charts show binding affinity (KD) comparisons.analyze_data
90
The slide uses a process diagram to show the AI workflow and a table to quantify the binding affinity (nM KD) improvements.illustrate_case
91
The slide uses a consistent visual metaphor of a Y-shaped antibody binding to three distinct targets in each of the three columns.present_solution
92
The slide uses a 5-column layout with icons to represent different capabilities of the platform.summarize
96
The chart uses a horizontal bar format to represent development progress. Color coding distinguishes between 'Potential First in Class' (blue) and 'Potential Beplan_implementation
97
Includes a biological pathway diagram (Takedatsu 2008) and market data points.size_opportunity
99
The chart is a dot plot showing affinity (KD) vs edit distance from parent binder. The benchmark is a horizontal dashed line.present_solution
100
The slide uses a side-by-side comparison structure to detail the value proposition of two specific drug candidates.present_solution
101
The slide illustrates a dual-pathway process leading to a unified AI-driven optimization step.present_solution
102
Includes a Kaplan-Meier survival curve and a biological diagram of TLS.analyze_data
103
The slide outlines a proprietary R&D workflow for antibody discovery.present_solution
105
The slide illustrates a scientific workflow for target discovery.illustrate_case
106
The chart shows a dose-dependent increase in absorbance for ABS-301 compared to isotype controls, suggesting binding/inhibition activity.present_solution
107
The slide uses a combination of a horizontal bar chart and a data table to quantify the addressable market.size_opportunity
108
The chart uses a horizontal bar format to represent development progress against a timeline of stages (Target Eval to IND).present_solution
110
The slide uses code snippets as decorative background elements.state_next_steps
Open slide detailBeat · Satisfaction